Insight

Infection Prevention and Management after CAR T Cell Therapy for Hematological Malignancies

Photo taken from www.acs.org

Aug 1, 2024, 03:35

Infection Prevention and Management after CAR T Cell Therapy for Hematological Malignancies

at Alfaisal University, shared a paper Zainab Shahid et al. on X, adding:

“Best Practice Considerations by The American Society of Transplant and Cellular Therapy:

Infection Prevention and Management after Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies.”

Source: Mostafa Faisal/X

Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management after Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies.

Authors: Zainab Shahid, Tania Jain, Veronica Dioverti, Martini Pennisi, Lekha Mikkilineni, Swetha Kambhampati, Nirali N Shah, Sanjeet Dadwal, Genovefa Papanicolaou, Mehdi Hamadani, Paul A. Carpenter, Gabriela Maron Alfaro, Susan K. Seo, and Joshua A. Hill.

Management

cancer Gabriela Maron Alfaro Genovefa Papanicolaou hematological malignancies Infection Prevention Joshua A. Hill Lekha Mikkilineni Martini Pennisi Mehdi Hamadani Mostafa Faisal Nirali N Shah OncoDaily Oncology Paul A. Carpenter Sanjeet Dadwal Susan K. Seo Swetha Kambhampati T-cell therapy Tania Jain The American Society of Transplant and Cellular Therapy Veronica Dioverti Zainab Shahid

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer